Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

24 oct. 2022 06h13 HE | Source: Research and Markets

Global Pneumococcal Vaccines Market Report 2022: Featuring Pfizer, Merck & Co, & GlaxoSmithKline

Dublin, Oct. 24, 2022 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccines Market, by Vaccine Type, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030"...
09 avr. 2021 06h48 HE | Source: Research and Markets

Global Pneumococcal Vaccines Disease Analysis Report 202: Overall Likelihood of Approval of a Phase I Pneumococcal Vaccine is 16.7%

Dublin, April 09, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Pneumococcal Vaccines" report has been added to ResearchAndMarkets.com's offering. The value of the pneumococcal vaccines market...
16 oct. 2020 05h38 HE | Source: Research and Markets

Pneumococcal Vaccines Market, 2024 - Prevnar 13 / Pneumovax 23 / V114 / PF-06482077

Dublin, Oct. 16, 2020 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccines Market and Forecast Analysis to 2024" report has been added to ResearchAndMarkets.com's offering. The value of the pneumococcal...